Molecular medicine is a discipline that is at the interface between clinical and basic biological research. It uses physical, chemical, biological and medical methods to describe, at molecular level, structures and mechanisms, to identify molecular or genetic modifications underlying pathologies and to develop possible molecular intervention strategies. The PhD in Molecular Medicine includes several disciplinary areas and is characterized by a wide multidisciplinarity, interdisciplinarity and transdisciplinarity in health research, including molecular, cellular, preclinical and clinical approaches in several topics, such as:
• Tumor genetics and epigenetics;
• Women’s health (eg, endometriosis, etc.), male infertility;
• Physiology and physiopathology of skeletal and cardiac muscle;
• Neurobiology of behavior.
• Physiopathology of subcellular organelles
The PhD in Molecular Medicine is also characterized by international scientific collaborations, along with an intense Ph. D. Student international mobility (from 6 to 12 months), due to the presence in the Faculty Board of highly qualified international institutions including: DKSF, Heidelberg and Ludwig-Maximillians-University, Munich, Germany; UCD, Conway Institute, Dublin, Ireland; INSERM, Grenoble and CNRS Lyon, France; the University of Minas Gerais, Belo Horizonte, Brazil; GSK Vaccines and Diagnostics, Siena, Italy; Sheba Medical Center, Israel; Sommelweis University, Budapest, Hungary; Nanjing University, China; Oxford Brookes University, Oxford, United Kingdom; Innsbruck Medical University, Austria; University Helsinki, Finland; University Pharmacy College, Salt Lake City, UT, and University of California at San Diego, UCSD, CA,USA.